首页> 外文期刊>Current hypertension reports. >Blood Pressure: Return of the Sympathetics?
【24h】

Blood Pressure: Return of the Sympathetics?

机译:血压:交感神经的回归?

获取原文
获取原文并翻译 | 示例
           

摘要

This brief review highlights new ideas about the role of the sympathetic nervous system in human blood pressure regulation. We emphasize how this role varies with age and sex and use our findings to raise questions about the sympathetic nervous system and hypertension in humans. We also focus on three additional areas, including (1) novel ideas about the carotid body and sympathoexcitation as it relates to hypertension, (2) clinical trials of renal denervation that attempted to treat hypertension by reducing ongoing sympathoexcitation, and (3) new ideas about resistant hypertension and cerebral blood flow. We further highlight that success of device-based therapy to modulate the sympathetic nervous system relies heavily on patient selection. Furthermore, data suggest that the majority of patients respond to anti-hypertensive therapy and the major cause of "resistant" hypertension is poor patient adherence. While the enthusiasm for device therapy or perhaps even "precision medicine" is high, it is likely that by far the most benefit to the most patients will occur via better screening, more aggressive therapy, and the development of strategies that improve patient adherence to medication regimens and lifestyle changes.
机译:本文简要介绍了关于交感神经系统在人体血压调节中作用的新观点。我们强调该角色如何随年龄和性别而变化,并利用我们的发现提出有关人类交感神经系统和高血压的问题。我们还将重点关注其他三个领域,其中包括:(1)关于与高血压有关的颈动脉体和交感神经兴奋的新观念,(2)尝试通过减少持续的交感神经兴奋来治疗高血压的肾脏去神经支配的临床试验,以及(3)新思路关于抵抗性高血压和脑血流量。我们进一步强调,基于设备的疗法能否成功调节交感神经系统,在很大程度上取决于患者的选择。此外,数据表明大多数患者对抗高血压治疗有反应,“耐药”高血压的主要原因是患者依从性差。尽管对器械疗法甚至“精密药物”的热情很高,但到目前为止,对大多数患者的最大益处可能将通过更好的筛查,更具侵略性的治疗以及改善患者对药物依从性的策略的发展而实现。养生方式和生活方式的改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号